Faculty of 1000 evaluation for Phase I study of neratinib in combination with temsirolimus in patients with human epidermal growth factor receptor 2-dependent and other solid tumors.
2004 ◽
Vol 10
(15)
◽
pp. 5027-5037
◽
2003 ◽
Vol 1
(5)
◽
pp. S167
◽
2017 ◽
Vol 6
(4)
◽
pp. 534-538
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 3018-3018
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 3061-3061